| 1 | leave this field empty | | | | | | | 3 | 0.69% |
| 2 | not been evaluated by | | | | | | | 2 | 0.46% |
| 3 | intended to diagnose treat | | | | | | | 2 | 0.46% |
| 4 | this field empty please | | | | | | | 2 | 0.46% |
| 5 | has not been evaluated | | | | | | | 2 | 0.46% |
| 6 | or prevent any disease | | | | | | | 2 | 0.46% |
| 7 | cure or prevent any | | | | | | | 2 | 0.46% |
| 8 | diagnose treat cure or | | | | | | | 2 | 0.46% |
| 9 | sabinsa press release sabinsa | | | | | | | 2 | 0.46% |
| 10 | to diagnose treat cure | | | | | | | 2 | 0.46% |
| 11 | treat cure or prevent | | | | | | | 2 | 0.46% |
| 12 | not intended to diagnose | | | | | | | 2 | 0.46% |
| 13 | been evaluated by the | | | | | | | 2 | 0.46% |
| 14 | please leave this field | | | | | | | 2 | 0.46% |
| 15 | utah usa japan australia | | | | | | | 1 | 0.23% |
| 16 | contact us please leave | | | | | | | 1 | 0.23% |
| 17 | contact list usa india | | | | | | | 1 | 0.23% |
| 18 | global contact list usa | | | | | | | 1 | 0.23% |
| 19 | australia poland brasil korea | | | | | | | 1 | 0.23% |
| 20 | poland brasil korea canada | | | | | | | 1 | 0.23% |
| 21 | japan australia poland brasil | | | | | | | 1 | 0.23% |
| 22 | korea canada south africa | | | | | | | 1 | 0.23% |
| 23 | canada south africa china | | | | | | | 1 | 0.23% |
| 24 | vietnam germany contact | | | | | | | 1 | 0.23% |
| 25 | infosabinsacom global contact list | | | | | | | 1 | 0.23% |
| 26 | germany contact us | | | | | | | 1 | 0.23% |
| 27 | contact us please | | | | | | | 1 | 0.23% |
| 28 | 1443 infosabinsacom global contact | | | | | | | 1 | 0.23% |
| 29 | usa japan australia poland | | | | | | | 1 | 0.23% |
| 30 | brasil korea canada south | | | | | | | 1 | 0.23% |
| 31 | this field empty © | | | | | | | 1 | 0.23% |
| 32 | us please leave this | | | | | | | 1 | 0.23% |
| 33 | policysitemapterms of usedisclaimer × | | | | | | | 1 | 0.23% |
| 34 | statement has not been | | | | | | | 1 | 0.23% |
| 35 | this statement has not | | | | | | | 1 | 0.23% |
| 36 | disclaimer usfda this statement | | | | | | | 1 | 0.23% |
| 37 | × disclaimer usfda this | | | | | | | 1 | 0.23% |
| 38 | usedisclaimer × disclaimer usfda | | | | | | | 1 | 0.23% |
| 39 | of usedisclaimer × disclaimer | | | | | | | 1 | 0.23% |
| 40 | by edkal technologies privacy | | | | | | | 1 | 0.23% |